Identification | Back Directory | [Name]
VX-702 | [CAS]
479543-46-9 | [Synonyms]
CS-363 1-(5-CarbaMoyl-6-(2,4-difluorophenyl)pyridin-2-yl)-1-(2,6-difluorophenyl)urea 6-(N-carbamoyl-2,6-difluoroanilino)-2-(2,4-difluorophenyl)pyridine-3-carboxamide | [Molecular Formula]
C19H12F4N4O2 | [MDL Number]
MFCD11616590 | [MOL File]
479543-46-9.mol | [Molecular Weight]
404.322 |
Hazard Information | Back Directory | [Uses]
VX 702 is a p38 MAP kinase pathway inhibitor. | [Definition]
ChEBI: 6-(N-carbamoyl-2,6-difluoroanilino)-2-(2,4-difluorophenyl)-3-pyridinecarboxamide is a phenylpyridine. | [Biological Activity]
Orally active, ATP-competitive inhibitor of p38α MAPK; also inhibits p38β (K D values are 3.7 and 17 nM respectively). |
|
Company Name: |
NCE Biomedical Co.,Ltd.
|
Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
Website: |
www.is0513.com/ShowSupplierProductsList15748/0.htm |
|